Dynamics of acute phase indices in patients with rheumatoid arthritis combined with abdominal obesity, type 2 diabetes mellitus and arterial hypertension depending on Т-786С eNOS gene polymorphism following treatment
Journal Title: Міжнародний ендокринологічний журнал - Year 2018, Vol 14, Issue 1
Abstract
Background. The development of modern approaches to the pharmacotherapy of rheumatoid arthritis (RA) associated with abdominal obesity (AO), type 2 diabetes mellitus (DM 2) and arterial hypertension (AH) remains relevant today. The purpose of the study was to investigate the dynamics of acute-phase indices following treatment in patients with RA combined with AO, DM 2 and AH, depending on the T-786C gene polymorphism of endothelial nitric oxide synthase (eNOS). Materials and methods. Sixty patients with RA and 20 apparently healthy persons passed the stage of screening. The polymorphism of the eNOS gene (rs2070744) was determined by polymerase chain reaction, and when evaluating the efficacy of treatment, the presence of comorbid pathology was taken into account. Results. Following treatment, the content of acute phase inflammation indices decreased: C-reactive protein in carriers of unfavorable СС-genotype — by 30.74 % (p = 0.002), TT-genotype — by 44.16 %, and TС-genotype — by 32.21 % (p < 0.001). The level of the rheumatoid factor decreased in the carriers of the TT-genotype by 49.66 % (p < 0.001), TС-genotype — by 26.46 % (p < 0.001) and СС-genotype — by 29.75 % (p < 0.001). The content of cyclic citrullinated peptide antibodies reduced only among carriers of the TT-genotype — by 10.79 % (p < 0.05). The level of antistreptolysin O has probably decreased by 14.07 and 21.44 %, with no statistically significant advantage in СС-genotype carriers (p > 0.05). The content of seromucoid and serum test parameters reduced in СС-genotype carriers by 19.52 (p < 0.05) and 24.56 % (p < 0.05), in carriers of the TT-genotype — by 13.84 (p < 0.05) and 18.71 % (p < 0.05) and TС-genotype — by 18.49 (p < 0.05) and 22.89 % (p < 0.001), respectively. Conclusions. After the treatment, the reduction in the content of the acute phase inflammation indices in the carriers of the TT-genotype was the most significant.
Authors and Affiliations
O. P. Bukach
Keywords
Related Articles
- EP ID EP275650
- DOI 10.22141/2224-0721.14.1.2018.127086
- Views 65
- Downloads 0
Hyperleptinemia as One of the Factors for Renal Dysfunction in Patients with Hypothyroidism
In order to study the features of renal function in patients with hypothyroidism we have examined 132 patients with primary hypothyroidism. The results showed that in patients with overt hypothyroidism there is renal dys...
Effect of Combination Therapy with Alpha-Lipoic Acid on the Fractalkine Level in Patients with Coronary Artery Disease and Type 2 Diabetes Mellitus
Background. The aim of research — to assess the fractalkine levels in patients with coronary artery disease (CAD), depending on the presence of type 2 diabetes mellitus (DM) and the nature of coronary artery lesions bef...
Endocrine and neurological diseases: problems of comorbidity
.
Possibilities of preoperative and intraoperative methods for the diagnosis of thyroid nodules
In case of thyroid nodules, it is important to determine the nature of the pathological process in a timely manner, since the algorithm for treating the patient depends on this. The main and effective method of preoperat...
Epidemiological Aspects of Diabetes Mellitus in Tashkent on the Basis of Register Data
The objective of research — an analysis of epidemiological aspects of diabetes mellitus (DM) type 1 and 2 in Tashkent. Materials and methods. Analysis of DM register was performed on the basis of the map registers in Ta...